Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
Open Access
Abstract
Background: Hepatocellular carcinoma (HCC) is a major contributor to cancer-related morbidity and mortality burdens globally. Given the fundamental metabolic activity of hepatocytes within the liver, hepatocarcinogenesis is bound to be characterized by alterations in metabolite profiles as a manifestation of metabolic reprogramming. Methods: HCC and adjacent non-tumoral liver specimens were obtained from patients after HCC resection. Global patterns in tissue metabolites were identified using non-targeted 1H Nuclear Magnetic Resonance (1H-NMR) spectroscopy whereas specific metabolites were quantified using targeted liquid chromatography–mass spectrometry (LC/MS). Results: Principal component analysis (PCA) within our 1H-NMR dataset identified a principal component (PC) one of 53.3%, along which the two sample groups were distinctively clustered. Univariate analysis of tissue specimens identified more than 150 metabolites significantly altered in HCC compared to non-tumoral liver. For LC/MS, PCA identified a PC1 of 45.2%, along which samples from HCC tissues and non-tumoral tissues were clearly separated. Supervised analysis (PLS–DA) identified decreases in tissue glutathione, succinate, glycerol-3-phosphate, alanine, malate, and AMP as the most important contributors to the metabolomic signature of HCC by LC/MS. Conclusions: Together, 1H-NMR and LC/MS metabolomics have the capacity to distinguish HCC from non-tumoral liver. The characterization of such distinct profiles of metabolite abundances underscores the major metabolic alterations that result from hepatocarcinogenesis.Keywords
Funding Information
- Chaire de recherche en hépatologie Novartis—Fondation canadienne du foie de l’Université de Montréal (32633, 30861, 298832, 30574)
- Chaire Roger Des Groseillers d’oncologie chirurgicale hépatobiliaire et pancréatique de l’Université de Montréal (32633, 30861, 298832, 30574)
- Santé (32633, 30861, 298832, 30574)
- Santé (32633, 30861, 298832, 30574)
- Institut du Cancer de Montréal establishment award (32633, 30861, 298832, 30574)
- Canadian Foundation for Innovation award (32633, 30861, 298832, 30574)
This publication has 43 references indexed in Scilit:
- Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolitesOncotarget, 2016
- The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyHypoxia, 2015
- Metabolic consequences of oncogenic IDH mutationsPharmacology & Therapeutics, 2015
- Oncometabolites: tailoring our genesThe FEBS Journal, 2015
- Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary diseaseJournal of Pharmaceutical and Biomedical Analysis, 2014
- Liver zonation: Novel aspects of its regulation and its impact on homeostasisWorld Journal of Gastroenterology, 2014
- A Review of Applications of Metabolomics in CancerMetabolites, 2013
- Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinomaWorld Journal of Gastroenterology, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- THE METABOLISM OF TUMORS IN THE BODYJournal of General Physiology, 1927